LNCAROD and hepatocellular carcinoma: As shown in Fig. 2 A-B, LNCAROD silencing in SNU-449 and HCC-LM3 cell lines decreased cell proliferation compared with their control counterparts, whereas LNCAROD overexpression significantly enhanced their proliferation (Figure S2A-B), demonstrating that LNCAROD has a potent HCC-promoting effect.